Categories: Business

Broker’s call: Gopal Snacks (Buy)

Target: ₹500

CMP: ₹284

We hosted the management team of Gopal Snacks, represented by Bipin Hadvani (MD and Promoter) and Naveen Gupta (Chief Business Officer) for domestic NDR.

We retain our Buy call on the expectation of market share recovery with 100 per cent restoration of in-house production by Q1FY26. So far, disruption from the fire has been managed well with a quick shift in production to 3P (now about 8-10 per cent of production) and a gradual shift back to own capacities. Modasa plant capacity augmentation is expected to be on stream from July 1. While actions are underway to recoup business in Gujarat with production ramp-up, the management has maintained its focus on enhancing fundamentals like gradual onboarding into quick commerce, entry in large modern trade, and expansion in the vending machine channel.

The company will face dual pressure of topline and margin in Q4, while full recovery with the return of growth and margin recoup is likely from Q3FY25. Management remains attentive to maintaining business fundamentals, which reflects in dealer connects and is further enhanced by relevant actions in the portfolio and supply chain.

Key risk to our call is the company’s inability to recoup market share on 100 per cent production recovery.

Source link

nasdaqpicks.com

Recent Posts

Euro hits four-month high after ECB slashes interest rates to 2.5%, sixth rate reduction in nine months

The euro touched a four-month peak against the U.S. dollar on Thursday after the European…

2 minutes ago

India ranks among top four markets in Asia for NetApp, say company execs

With India emerging as one of NetApp’s fastest-growing and top four markets in Asia, the…

4 minutes ago

EU puts on show of solidarity with Volodymyr Zelenskyy after clash with Donald Trump

Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election…

6 minutes ago

Regional cinema gets a digital lifeline as States launch their own OTTs

Stepping into the streaming arena, State governments are rolling out their own OTT platforms to…

11 minutes ago

Biocon Biologics to supply insulin Aspart drug substance to Civica for US market

Biocon Biologics Ltd, a fully integrated global biosimilars company and a subsidiary of Biocon, has…

20 minutes ago

UK lifts restrictions on Syria’s central bank in sanctions relief

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

22 minutes ago